<b>Background</b><b>:</b><b> </b>Antifungal resistance (AFR) is a global public health problem with devastating effects, especially among immunocompromised individuals. Addressing AFR requires a One Health approach including Antifungal Stewardship (AFS). This study aimed to comprehensively review global studies published on fungal infections and AFR and to recommend solutions to address this growing problem. <b>Materials and </b><b>Methods</b><b>: </b>This was a narrative review that was conducted using published papers on fungal infections, AFR, and AFS between January 1961 and March 2024. The literature was searched using PubMed, Google Scholar, Web of Science, and EMBASE. <b>Results</b><b>: </b>This found that there has been an increase in fungal infections globally, especially among immunocompromised patients. Due to this increase in fungal infections, there has been a proportionate increase in the use of antifungal agents to prevent and treat fungal infections. This increased use of antifungal agents has worsened the problem of AFR contributing to increased morbidity and mortality. Globally, fungal infections have contributed to 150 million infections annually and 1.7 million deaths per year. By the year 2023, over 3.8 million people died from fungal infections. Addressing AFR remains a challenge because the treatment of antifungal-resistant infections is difficult. Finally, the treatment of fungal infections is a global challenge exacerbated by the limited number of antifungal agents to treat invasive fungal infections. <b>Co</b><b>n</b><b>clusion</b><b>: </b>The results of this study indicated that fungal infections and AFR are prevalent across humans, animals, agriculture, and the environment. Addressing this problem requires the provision of solutions such as improving the awareness of AFR, conducting further research on the discovery of new antifungal agents, and implementing AFS programs. If this global problem is not addressed, the morbidity and mortality associated with AFR will continue to rise in the future.
Kontoyiannis, D.P. (2017) Antifungal Resistance: An Emerging Reality and a Global Challenge. The Journal of Infectious Diseases , 216, S431-S435. https://doi.org/10.1093/infdis/jix179
Vitiello, A., Ferrara, F., Boccellino, M., Ponzo, A., Cimmino, C., Comberiati, E., Zovi, A., Clemente, S. and Sabbatucci, M. (2023) Antifungal Drug Resistance: An Emergent Health Threat. Biomedicines , 11, Article 1063. https://doi.org/10.3390/biomedicines11041063
Mudenda, S., Matafwali, S.K., Mukosha, M., Daka, V., Chabalenge, B., Chizimu, J., Yamba, K., Mufwambi, W., Banda, P., Chisha, P., et al. (2023) Antifungal Resistance and Stewardship: A Knowledge, Attitudes and Practices Survey among Pharmacy Students at the University of Zambia; Findings and Implications. JAC-Antimicrobal Resistance , 5, dlad141. https://doi.org/10.1093/jacamr/dlad141
Arastehfar, A., Gabaldón, T., Garcia-Rubio, R., Jenks, J.D., Hoenigl, M., Salzer, H.J.F., Ilkit, M., Lass-Flörl, C. and Perlin, D.S. (2020) Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium. Ant i biotics , 9, Article 877. https://doi.org/10.3390/antibiotics9120877
Berman, J. and Krysan, D.J. (2020) Drug Resistance and Tolerance in Fungi. Nature Reviews Microbiology , 18, 319-331. https://doi.org/10.1038/s41579-019-0322-2
Ben-Ami, R. and Kontoyiannis, D.P. (2021) Resistance to Antifungal Drugs. Infe c tious Disease Clinics of North America , 35, 279-311. https://doi.org/10.1016/j.idc.2021.03.003
Nicola, A.M., Albuquerque, P., Paes, H.C., Fernandes, L., Costa, F.F., Kioshima, E.S., Abadio, A.K.R., Bocca, A.L. and Felipe, M.S. (2019) Antifungal Drugs: New Insights in Research & Development. Pharmacology & Therapeutics , 195, 21-38. https://doi.org/10.1016/j.pharmthera.2018.10.008
Osherov, N. and Kontoyiannis, D.P. (2017) The Anti- Aspergillus Drug Pipeline: Is the Glass Half Full or Empty? Medical Mycology , 55, 118-124. https://doi.org/10.1093/mmy/myw060
Murray, C.J., Ikuta, K.S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., Han, C., Bisignano, C., Rao, P., Wool, E., et al. (2022) Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis. The Lancet , 399, 629-655. https://doi.org/10.1016/S0140-6736(21)02724-0
Prestinaci, F., Pezzotti, P. and Pantosti, A. (2015) Antimicrobial Resistance: A Global Multifaceted Phenomenon. Pathogens and Global Health , 109, 309-318. https://doi.org/10.1179/2047773215Y.0000000030
Tang, K.W.K., Millar, B.C. and Moore, J.E. (2023) Antimicrobial Resistance (AMR). British Journal of Biomedical Science , 80, Article 11387. https://doi.org/10.3389/bjbs.2023.11387
Arip, M., Selvaraja, M., Mogana, R., Tan, L.F., Leong, M.Y., Tan, P.L., Yap, V.L., Chinnapan, S., Tat, N.C., Abdullah, M., et al. (2022) Review on Plant-Based Management in Combating Antimicrobial Resistance—Mechanistic Perspective. Fro n tiers in Pharmacology , 13, Article 879495. https://doi.org/10.3389/fphar.2022.879495
Ikuta, K.S., Swetschinski, L.R., Robles Aguilar, G., Sharara, F., Mestrovic, T., Gray, A.P., Davis Weaver, N., Wool, E.E., Han, C., Gershberg Hayoon, A., et al. (2022) Global Mortality Associated with 33 Bacterial Pathogens in 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. The Lancet , 400, 2221-2248. https://doi.org/10.1016/S0140-6736(22)02185-7
Srinivasan, A., Lopez-Ribot, J.L. and Ramasubramanian, A.K. (2014) Overcoming Antifungal Resistance. Drug Discovery Today : Technologies , 11, 65-71. https://doi.org/10.1016/j.ddtec.2014.02.005
Dadgostar, P. (2019) Antimicrobial Resistance: Implications and Costs. Infection and Drug Resistance , 12, 3903-3910. https://doi.org/10.2147/IDR.S234610
Jonas, O.B., Irwin, A., Berthe, F.C.J., Le Gall, F.G. and Marquez, P. (2017) Drug-Resistant Infections: A Threat to Our Economic Future. World Bank Report, 1-132. https://documents1.worldbank.org/curated/en/323311493396993758/pdf/final-report.pdf
O’Neill, J. (2014) Review on Antibiotic Resistance. Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations. https://wellcomecollection.org/works/rdpck35v
O’Neill, J. (2016) Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. The Review on Antimicrobial Resistance. https://amr-review.org/sites/default/files/160518_Final paper_with cover.pdf
World Health Organization (2022) WHO Fungal Priority Pathogens List to Guide Research, Development and Public Health Action, Vol. 1, 1-48. https://www.who.int/publications/i/item/9789240060241
Kainz, K., Bauer, M.A., Madeo, F. and Carmona-Gutierrez, D. (2020) Fungal Infections in Humans: The Silent Crisis. Microbial Cell , 7, 143-145. https://doi.org/10.15698/mic2020.06.718
Fang, W., Wu, J., Cheng, M., Zhu, X., Du, M., Chen, C., Liao, W., Zhi, K. and Pan, W. (2023) Diagnosis of Invasive Fungal Infections: Challenges and Recent Developments. Journal of Biomedical Science , 30, Article No. 42. https://doi.org/10.1186/s12929-023-00926-2
Brown, G.D., Denning, D.W., Gow, N.A.R., Levitz, S.M., Netea, M.G. and White, T.C. (2012) Hidden Killers: Human Fungal Infections. Science Translational Med i cine , 4, 165rv13. https://doi.org/10.1126/scitranslmed.3004404
Calandra, T., Roberts, J.A., Antonelli, M., Bassetti, M. and Vincent, J.L. (2016) Diagnosis and Management of Invasive Candidiasis in the ICU: An Updated Approach to an Old Enemy. Critical Care , 20, Article No. 125. https://doi.org/10.1186/s13054-016-1313-6
Reddy, G.K.K., Padmavathi, A.R. and Nancharaiah, Y.V. (2022) Fungal Infections: Pathogenesis, Antifungals and Alternate Treatment Approaches. Current Research in Microbial Sciences , 3, Article 100137. https://doi.org/10.1016/j.crmicr.2022.100137
Verweij, P.E., Chowdhary, A., Melchers, W.J.G. and Meis, J.F. (2016) Azole Resistance in Aspergillus fumigatus : Can We Retain the Clinical Use of Mold-Active Antifungal Azoles? Clinical Infectious Diseases , 62, 362-368. https://doi.org/10.1093/cid/civ885
Koehler, P., Bassetti, M., Chakrabarti, A., Chen, S.C.A., Colombo, A.L., Hoenigl, M., Klimko, N., Lass-Flörl, C., Oladele, R.O., Vinh, D.C., et al. (2021) Defining and Managing COVID-19-Associated Pulmonary Aspergillosis: The 2020 ECMM/ISHAM Consensus Criteria for Research and Clinical Guidance. The Lancet Infectious Di s eases , 21, e149-e162. https://doi.org/10.1016/S1473-3099(20)30847-1
van Arkel, A.L.E., Rijpstra, T.A., Belderbos, H.N.A., van Wijngaarden, P., Verweij, P.E. and Bentvelsen, R.G. (2020) COVID-19-Associated Pulmonary Aspergillosis. American Journal of Respiratory and Critical Care Medicine , 202, 132-135. https://doi.org/10.1164/rccm.202004-1038LE
Negm, E.M., Mohamed, M.S., Rabie, R.A., Fouad, W.S., Beniamen, A., Mosallem, A., Tawfik, A.E. and Salama, H.M. (2023) Fungal Infection Profile in Critically Ill COVID-19 Patients: A Prospective Study at a Large Teaching Hospital in a Middle-Income Country. BMC Infectious Diseases , 23, Article No. 246. https://doi.org/10.1186/s12879-023-08226-8
Hoenigl, M., Seidel, D., Sprute, R., Cunha, C., Oliverio, M., Goldman, G.H., Ibrahim, A.S. and Carvalho, A. (2022) COVID-19-Associated Fungal Infections. Nature Microbiology , 7, 1127-1140. https://doi.org/10.1038/s41564-022-01172-2
Dubey, R., Sen, K.K., Mohanty, S.S., Panda, S., Goyal, M. and Menon, S.M. (2022) The Rising Burden of Invasive Fungal Infections in COVID-19, Can Structured CT Thorax Change the Game. Egyptian Journal of Radiology and Nuclear Medicine , 53, Article No. 18. https://doi.org/10.1186/s43055-022-00694-3
Arastehfar, A., Shaban, T., Zarrinfar, H., Roudbary, M., Ghazanfari, M., Hedayati, M.T., Sedaghat, A., Ilkit, M., Najafzadeh, M.J. and Perlin, D.S. (2021) Candidemia among Iranian Patients with Severe COVID-19 Admitted to ICUs. Journal of Fungi , 7, Article 280. https://doi.org/10.3390/jof7040280
Villanueva-Lozano, H., Treviño-Rangel, R. de J., González, G.M., Ramírez-Elizondo, M.T., Lara-Medrano, R., Aleman-Bocanegra, M.C., Guajardo-Lara, C.E., Gaona-Chávez, N., Castilleja-Leal, F., Torre-Amione, G., et al. (2021) Outbreak of Candida auris Infection in a COVID-19 Hospital in Mexico. Clinical Microbiology and Infection , 27, 813-816. https://doi.org/10.1016/j.cmi.2020.12.030
Cataldo, M.A., Tetaj, N., Selleri, M., Marchioni, L., Capone, A., Caraffa, E., Di Caro, A. and Petrosillo, N. (2020) Incidence of Bacterial and Fungal Bloodstream Infections in COVID-19 Patients in Intensive Care: An Alarming “Collateral Effect”. Journal of Global Antimicrobial Resistance , 23, 290-291. https://doi.org/10.1016/j.jgar.2020.10.004
Ramadan, H.K.A., Mahmoud, M.A., Zakaria, M., Aburahma; Elkhawaga, A.A., El-Mokhtar, M.A., Sayed, I.M., Hosni, A., Hassany, S.M. and Medhat, M.A. (2020) Predictors of Severity and Co-Infection Resistance Profile in COVID-19 Patients: First Report from Upper Egypt. Infection and Drug Resistance , 13, 3409-3422. https://doi.org/10.2147/IDR.S272605
Denning, D. (2024) Global Incidence and Mortality of Severe Fungal Disease. The Lancet Infectious Diseases . https://doi.org/10.1016/S1473-3099(23)00692-8
Dall, C. (2024) Global Mortality from Fungal Diseases Has Nearly Doubled. https://www.cidrap.umn.edu/antimicrobial-stewardship/global-mortality-fungal-diseases-has-nearly-doubled
Ghannoum, M.A. and Rice, L.B. (1999) Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance. Clinical Microbiology Reviews , 12, 501-517. https://doi.org/10.1128/CMR.12.4.501
Nami, S., Aghebati-Maleki, A., Morovati, H. and Aghebati-Maleki, L. (2019) Current Antifungal Drugs and Immunotherapeutic Approaches as Promising Strategies to Treatment of Fungal Diseases. Biomedicine & Pharmacotherapy , 110, 857-868. https://doi.org/10.1016/j.biopha.2018.12.009
Hossain, C.M., Ryan, L.K., Gera, M., Choudhuri, S., Lyle, N., Ali, K.A. and Diamond, G. (2022) Antifungals and Drug Resistance. Encyclopedia , 2, 1722-1737. https://doi.org/10.3390/encyclopedia2040118
Fisher, M.C., Alastruey-Izquierdo, A., Berman, J., Bicanic, T., Bignell, E.M., Bowyer, P., Bromley, M., Brüggemann, R., Garber, G., Cornely, O.A., et al. (2022) Tackling the Emerging Threat of Antifungal Resistance to Human Health. Nature Reviews Microbiology , 20, 557-571. https://doi.org/10.1038/s41579-022-00720-1
Robbins, N., Caplan, T. and Cowen, L.E. (2017) Molecular Evolution of Antifungal Drug Resistance. The Annual Review of Microbiology , 71, 753-775. https://doi.org/10.1146/annurev-micro-030117-020345
Pathadka, S., Yan, V.K.C., Neoh, C.F., Al-Badriyeh, D., Kong, D.C.M., Slavin, M.A., Cowling, B.J., Hung, I.F.N., Wong, I.C.K. and Chan, E.W. (2022) Global Consumption Trend of Antifungal Agents in Humans from 2008 to 2018: Data from 65 Middle-and High-Income Countries. Drugs , 82, 1193-1205. https://doi.org/10.1007/s40265-022-01751-x
Osset-Trénor, P., Pascual-Ahuir, A. and Proft, M. (2023) Fungal Drug Response and Antimicrobial Resistance. Journal of Fungi , 9, Article 565. https://doi.org/10.3390/jof9050565
Dhasarathan, P., AlSalhi, M.S., Devanesan, S., Subbiah, J., Ranjitsingh, A.J.A., Binsalah, M. and Alfuraydi, A.A. (2021) Drug Resistance in Candida albicans Isolates and Related Changes in the Structural Domain of Mdr1 Protein. Journal of Infe c tion and Public Health , 14, 1848-1853. https://doi.org/10.1016/j.jiph.2021.11.002
Papadimitriou-Olivgeris, M., Andrianaki, A.M., Marangos, M., Sipsas, N., Apostolidi, E.A., Maltezos, E., Panagopoulos, P., Karapiperis, D., Arvaniti, K., Perdikouri, E.I., et al. (2020) Hospital-Wide Antifungal Prescription in Greek Hospitals: A Multicenter Repeated Point-Prevalence Study. European Journal of Clinical Microbio l ogy & Infectious Diseases , 39, 243-248. https://doi.org/10.1007/s10096-019-03713-w
Russo, T.P. and Santaniello, A. (2023) Tackling Antibiotic and Antifungal Resistance in Domestic Animals, Synanthropic Species, and Wildlife: A Global Health Imperative. Antibiotics , 12, Article 1632. https://doi.org/10.3390/antibiotics12111632
Brauer, V.S., Rezende, C.P., Pessoni, A.M., De Paula, R.G., Rangappa, K.S., Nayaka, S.C., Gupta, V.K. and Almeida, F. (2019) Antifungal Agents in Agriculture: Friends and Foes of Public Health. Biomolecules , 9, Article 521. https://doi.org/10.3390/biom9100521
Miller, S.A., Ferreira, J.P. and Lejeune, J.T. (2022) Antimicrobial Use and Resistance in Plant Agriculture: A One Health Perspective. Agriculture , 12, Article 289. https://doi.org/10.3390/agriculture12020289
Monapathi, M.E., Oguegbulu, J.C., Adogo, L., Klink, M., Okoli, B., Mtunzi, F. and Modise, J.S. (2021) Pharmaceutical Pollution: Azole Antifungal Drugs and Resistance of Opportunistic Pathogenic Yeasts in Wastewater and Environmental Water. Applied and Environmental Soil Science , 2021, Article ID: 9985398. https://doi.org/10.1155/2021/9985398
Fisher, M.C., Hawkins, N.J., Sanglard, D. and Gurr, S.J. (2018) Worldwide Emergence of Resistance to Antifungal Drugs Challenges Human Health and Food Security. Science , 360, 739-742. https://doi.org/10.1126/science.aap7999
Osorio-Lombana, J.P., Cuervo-Maldonado, S.I., López-Mora, M.J. and Gómez-Rincón, J.C. (2019) Prescripción Inapropiada de Antifúngicos y La Necesidad de Programas Para Su Uso Racional. Revista Chilena de Infectología , 36, 403-413. https://doi.org/10.4067/S0716-10182019000400403
Mudenda, S., Daka, V., Matafwali, S.K., Kanaan, M.H.G., Abdullah, S.S., Mohamed, S., Mufwambi, W., Kasanga, M., Mulenga, B., Chabalenge, B., et al. (2023) Prevalence of Self-Medication and Associated Factors among Healthcare Students during the COVID-19 Pandemic: A Cross-Sectional Study at the University of Zambia. Open Journal of Social Sciences , 11, 340-363. https://doi.org/10.4236/jss.2023.1110021
Mudenda, S., Mukela, M., Matafwali, S., Banda, M., Mutati, R.K., Muungo, L.T., Daka, V., Saad, S.A.M., Bumbangi, F.N. and Chabalenge, B. (2022) Knowledge, Attitudes, and Practices towards Antibiotic Use and Antimicrobial Resistance among Pharmacy Students at the University of Zambia: Implications for Antimicrobial Stewardship Programmes. Scholars Academic Journal of Pharmacy , 11, 117-124. https://doi.org/10.36347/sajp.2022.v11i08.002
Ngoma, M.T., Sitali, D., Mudenda, S., Mukuma, M., Bumbangi, F.N., Bunuma, E., Skjerve, E. and Muma, J.B. (2024) Community Antibiotic Consumption and Associated Factors in Lusaka District of Zambia: Findings and Implications for Antimicrobial Resistance and Stewardship. JAC-Antimicrobal Resistance , 6, dlae034. https://doi.org/10.1093/jacamr/dlae034
Kalungia, A.C., Burger, J., Godman, B., de Oliveira Costa, J. and Simuwelu, C. (2016) Non-Prescription Sale and Dispensing of Antibiotics in Community Pharmacies in Zambia. Expert Review of Anti-Infective Therapy , 14, 1215-1223. https://doi.org/10.1080/14787210.2016.1227702
Morgan, D.J., Okeke, I.N., Laxminarayan, R., Perencevich, E.N. and Weisenberg, S. (2011) Non-Prescription Antimicrobial Use Worldwide: A Systematic Review. The Lancet Infectious Diseases , 11, 692-701. https://doi.org/10.1016/S1473-3099(11)70054-8
Langfeldt, A., Gold, J.A.W. and Chiller, T. (2022) Emerging Fungal Infections: From the Fields to the Clinic, Resistant Aspergillus fumigatus and Dermatophyte Species: A One Health Perspective on an Urgent Public Health Problem. Current Clinical Microbiology Reports , 9, 46-51. https://doi.org/10.1007/s40588-022-00181-3
Hassoun, N., Kassem, I.I., Hamze, M., El Tom, J., Papon, N. and Osman, M. (2023) Antifungal Use and Resistance in a Lower-Middle-Income Country: The Case of Lebanon. Antibiotics , 12, Article 1063. https://doi.org/10.3390/antibiotics12091413
Mudenda, S., Chilimboyi, R., Matafwali, S.K., Daka, V., Lindizyani Mfune, R., Arielle, L., Kemgne, M., Bumbangi, F.N., Hangoma, J., Chabalenge, B., et al. (2024) Hospital Prescribing Patterns of Antibiotics in Zambia Using the WHO Prescribing Indicators Post-COVID-19 Pandemic: Findings and Implications. JAC-Antimicro bal Resistance , 6, dlae023. https://doi.org/10.1093/jacamr/dlae023
Mudenda, S., Chomba, M., Chabalenge, B., Hikaambo, C.N., Banda, M., Daka, V., Zulu, A., Mukesela, A., Kasonde, M., Lukonde, P., et al. (2022) Antibiotic Prescribing Patterns in Adult Patients According to the WHO AWaRe Classification: A Multi-Facility Cross-Sectional Study in Primary Healthcare Hospitals in Lusaka, Zambia. Pharmacology & Pharmacy , 13, 379-392. https://doi.org/10.4236/pp.2022.1310029
Sono, T.M., Yeika, E., Cook, A., Kalungia, A., Opanga, S.A., Acolatse, J.E.E., Sefah, I.A., Jelić, A.G., Campbell, S., Lorenzetti, G., et al. (2023) Current Rates of Purchasing of Antibiotics without a Prescription across Sub-Saharan Africa; Rationale and Potential Programmes to Reduce Inappropriate Dispensing and Resistance. Expert Review of Anti-Infective Therapy , 21, 1025-1055. https://doi.org/10.1080/14787210.2023.2259106
Yamba, K., Mudenda, S., Mpabalwani, E., Mainda, G., Mukuma, M., Samutela, M.T., Lukwesa, C., Chizimu, J., Kaluba, C.K., Mutalange, M., et al. (2024) Antibiotic Prescribing Patterns and Carriage of Antibiotic-Resistant Escherichia Coli and Enterococcus Species in Healthy Individuals from Selected Communities in Lusaka and Ndola Districts, Zambia. JAC-Antimicrobal Resistance , 6, dlae027. https://doi.org/10.1093/jacamr/dlae027
Lamb, D., Kelly, D., Manning, N. and Kelly, S. (2006) Reduced Intracellular Accumulation of Azole Antifungal Results in Resistance in Candida albicans Isolate NCPF 3363. FEMS Microbiology Letters , 147, 189-193. https://doi.org/10.1111/j.1574-6968.1997.tb10240.x
Cowen, L.E., Sanglard, D., Howard, S.J., Rogers, P.D. and Perlin, D.S. (2015) Mechanisms of Antifungal Drug Resistance. Cold Spring Harbor Perspectives in Med i cine , 5, a019752. https://doi.org/10.1101/cshperspect.a019752
Michaelides, P., Rosenthal, S.A., Sulzberger, M.B. and Witten, V.H. (1961) Trich o phyton tonsurans Infection Resistant to Griseofulvin: A Case Demonstrating Clinical and in Vitro Resistance. Archives of Dermatology , 83, 988-990. https://doi.org/10.1001/archderm.1961.01580120100025
Wiederhold, N.P. (2017) Antifungal Resistance: Current Trends and Future Strategies to Combat. Infection and Drug Resistance , 10, 249-259. https://doi.org/10.2147/IDR.S124918
Arendrup, M.C. (2014) Update on Antifungal Resistance in Aspergillus and Candida. Clinical Microbiology and Infection , 20, 42-48. https://doi.org/10.1111/1469-0691.12513
Mayr, A. and Lass-Flörl, C. (2011) Epidemiology and Antifungal Resistance in Invasive Aspergillosis According to Primary Disease—Review of the Literature. Eur o pean Journal of Medical Research , 16, 153-157. https://doi.org/10.1186/2047-783X-16-4-153
Sugui, J.A., Peterson, S.W., Figat, A., Hansen, B., Samson, R.A., Mellado, E., Cuenca-Estrella, M. and Kwon-Chung, K.J. (2014) Genetic Relatedness versus Biological Compatibility between Aspergillus fumigatus and Related Species. Journal of Clin i cal Microbiology , 52, 3707-3721. https://doi.org/10.1128/JCM.01704-14
Daneshnia, F., de Almeida Júnior, J.N., Ilkit, M., Lombardi, L., Perry, A.M., Gao, M., Nobile, C.J., Egger, M., Perlin, D.S., Zhai, B., et al. (2023) Worldwide Emergence of Fluconazole-Resistant Candida parapsilosis : Current Framework and Future Research Roadmap. The Lancet Microbe , 4, e470-e480. https://doi.org/10.1016/S2666-5247(23)00067-8
Park, S., Kelly, R., Kahn, J.N., Robles, J., Hsu, M.J., Register, E., Li, W., Vyas, V., Fan, H., Abruzzo, G., et al. (2005) Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical Candida Sp. Isolates. Antimicrobial Agents and Chemotherapy , 49, 3264-3273. https://doi.org/10.1128/AAC.49.8.3264-3273.2005
Walker, L.A., Gow, N.A.R. and Munro, C.A. (2010) Fungal Echinocandin Resistance. Fungal Genetics and Biology , 47, 117-126. https://doi.org/10.1016/j.fgb.2009.09.003
Denning, D.W. (2022) Antifungal Drug Resistance: An Update. European Journal of Hospital Pharmacy , 29, 109-112. https://doi.org/10.1136/ejhpharm-2020-002604
Bongomin, F., Gago, S., Oladele, R.O. and Denning, D.W. (2017) Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision. Journal of Fungi , 3, Article 57. https://doi.org/10.3390/jof3040057
Peghin, M., Vena, A., Graziano, E., Giacobbe, D.R., Tascini, C. and Bassetti, M. (2022) Improving Management and Antimicrobial Stewardship for Bacterial and Fungal Infections in Hospitalized Patients with COVID-19. Therapeutic Advances in Infectious Disease , 9. https://doi.org/10.1177/20499361221095732
Mudenda, S., Chabalenge, B., Kasanga, M., Mufwambi, W., Mfune, R.L., Daka, V. and Matafwali, S.K. (2023) Antifungal Resistance and Stewardship: A Call to Action in Zambia. PAMJ , 45, Article 152. https://doi.org/10.11604/pamj.2023.45.152.41232
Micallef, C., Aliyu, S.H., Santos, R., Brown, N.M., Rosembert, D. and Enoch, D.A. (2014) Introduction of an Antifungal Stewardship Programme Targeting High-Cost Antifungals at a Tertiary Hospital in Cambridge, England. Journal of Antimicrobial Chemotherapy , 70, 1908-1911. https://doi.org/10.1093/jac/dkv040
Hamdy, R.F., Zaoutis, T.E. and Seo, S.K. (2017) Antifungal Stewardship Considerations for Adults and Pediatrics. Virulence , 8, 658-672. https://doi.org/10.1080/21505594.2016.1226721
Ray, A., Das, A. and Panda, S. (2023) Antifungal Stewardship: What We Need to Know. Indian Journal of Dermatology , Venereology and Leprology , 89, 5-11. https://doi.org/10.25259/IJDVL_91_2022
Kara, E., Metan, G., Bayraktar-Ekincioglu, A., Gulmez, D., Arikan-Akdagli, S., Demirkazik, F., Akova, M., Unal, S. and Uzun, O. (2021) Implementation of Pharmacist-Driven Antifungal Stewardship Program in a Tertiary Care Hospital. Antim i crobial Agents and Chemotherapy , 65, e00629-21. https://doi.org/10.1128/AAC.00629-21
Valerio, M., Muñoz, P., Rodríguez, C.G., Caliz, B., Padilla, B., Fernández-Cruz, A., Sánchez-Somolinos, M., Gijón, P., Peral, J., Gayoso, J., et al. (2015) Antifungal Stewardship in a Tertiary-Care Institution: A Bedside Intervention. Clinical Microb i ology and Infection , 21, 492.e1-492.e9. https://doi.org/10.1016/j.cmi.2015.01.013
Firacative, C. (2020) Invasive Fungal Disease in Humans: Are We Aware of the Real Impact? Memórias do Instituto Oswaldo Cruz , 115, e200430. https://doi.org/10.1590/0074-02760200430
Mudenda, S., Chabalenge, B., Daka, V., Mfune, R.L., Salachi, K.I., Mohamed, S., Mufwambi, W., Kasanga, M., Matafwali, S.K., Mudenda, S., et al. (2023) Global Strategies to Combat Antimicrobial Resistance: A One Health Perspective. Pha r macology & Pharmacy , 14, 271-328. https://doi.org/10.4236/pp.2023.148020
Haque, M., McKimm, J., Sartelli, M., Dhingra, S., Labricciosa, F.M., Islam, S., Jahan, D., Nusrat, T., Chowdhury, T.S., Coccolini, F., et al. (2020) Strategies to Prevent Healthcare-Associated Infections: A Narrative Overview. Risk Management and Healthcare Policy , 13, 1765-1780. https://doi.org/10.2147/RMHP.S269315
Probst, V., Islamovic, F. and Mirza, A. (2021) Antimicrobial Stewardship Program in Pediatric Medicine. Pediatric Investigation , 5, 229-238. https://doi.org/10.1002/ped4.12292
Machowska, A. and Lundborg, C.S. (2019) Drivers of Irrational Use of Antibiotics in Europe. International Journal of Environmental Research and Public Health , 16, Article 27. https://doi.org/10.3390/ijerph16010027
Selvarajan, R., Obize, C., Sibanda, T., Abia, A.L.K. and Long, H. (2023) Evolution and Emergence of Antibiotic Resistance in Given Ecosystems: Possible Strategies for Addressing the Challenge of Antibiotic Resistance. Antibiotics , 12, Article 28. https://doi.org/10.3390/antibiotics12010028
Klepser, M.E., Ernst, E.J. and Pfaller, M.A. (1997) Update on Antifungal Resistance. Trends in Microbiology , 5, 372-375. https://doi.org/10.1016/S0966-842X(97)01108-6
Kanafani, Z.A. and Perfect, J.R. (2008) Resistance to Antifungal Agents: Mechanisms and Clinical Impact. Clinical Infectious Diseases , 46, 120-128. https://doi.org/10.1086/524071
Pfaller, M.A. (2012) Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment. The American Journal of Medicine , 125, S3-S13. https://doi.org/10.1016/j.amjmed.2011.11.001
Agrawal, S., Barnes, R., Brüggemann, R.J., Rautemaa-Richardson, R. and Warris, A. (2016) The Role of the Multidisciplinary Team in Antifungal Stewardship. Journal of Antimicrobial Chemotherapy , 71, ii37-ii42. https://doi.org/10.1093/jac/dkw395
Vandeputte, P., Ferrari, S. and Coste, A.T. (2012) Antifungal Resistance and New Strategies to Control Fungal Infections. International Journal of Microbiology , 2012, Article ID: 713687. https://doi.org/10.1155/2012/713687
Burki, T. (2023) WHO Publish Fungal Priority Pathogens List. The Lancet Microbe , 4, E74. https://doi.org/10.1016/S2666-5247(23)00003-4
Paneri, M., Sevta, P., Paneri, M. and Sevta, P. (2023) Overview of Antimicrobial Resistance: An Emerging Silent Pandemic. Global Journal of Medical Pharmaceutical and Biomedical Update , 18, 11. https://doi.org/10.25259/GJMPBU_153_2022
Pfavayi, L.T., Denning, D.W., Baker, S., Sibanda, E.N. and Mutapi, F. (2021) Determining the Burden of Fungal Infections in Zimbabwe. Scientific Reports , 11, Article No. 13240. https://doi.org/10.1038/s41598-021-92605-1
Prestel, C., Anderson, E., Forsberg, K., Lyman, M., de Perio, M.A., Kuhar, D., Edwards, K., Rivera, M., Shugart, A., Walters, M., et al. (2021) Candida auris Outbreak in a COVID-19 Specialty Care Unit—Florida, July-August 2020. Morbidity and Mortality Weekly Reports , 70, 56-57. https://doi.org/10.15585/mmwr.mm7002e3
Meijer, E.F.J., Dofferhoff, A.S.M., Hoiting, O. and Meis, J.F. (2021) COVID-19-Associated Pulmonary Aspergillosis: A Prospective Single-Center Dual Case Series. Mycoses , 64, 457-464. https://doi.org/10.1111/myc.13254
Rawson, T.M., Moore, L.S.P., Zhu, N., Ranganathan, N., Skolimowska, K., Gilchrist, M., Satta, G., Cooke, G. and Holmes, A. (2020) Bacterial and Fungal Coinfection in Individuals with Coronavirus: A Rapid Review to Support COVID-19 Antimicrobial Prescribing. Clinical Infectious Diseases , 71, 2459-2468. https://doi.org/10.1093/cid/ciaa530
Nucci, M., Barreiros, G., Guimarães, L.F., Deriquehem, V.A.S., Castiñeiras, A.C. and Nouér, S.A. (2021) Increased Incidence of Candidemia in a Tertiary Care Hospital with the COVID-19 Pandemic. Mycoses , 64, 152-156. https://doi.org/10.1111/myc.13225
Falcone, M., Tiseo, G., Giordano, C., Leonildi, A., Menichini, M., Vecchione, A., Pistello, M., Guarracino, F., Ghiadoni, L., Forfori, F., et al. (2020) Predictors of Hospital-Acquired Bacterial and Fungal Superinfections in COVID-19: A Prospective Observational Study. Journal of Antimicrobial Chemotherapy , 76, 1078-1084. https://doi.org/10.1093/jac/dkaa530
Mastrangelo, A., Germinario, B.N., Ferrante, M., Frangi, C., Li Voti, R., Muccini, C. and Ripa, M. (2021) Candidemia in Coronavirus Disease 2019 (COVID-19) Patients: Incidence and Characteristics in a Prospective Cohort Compared with Historical Non-COVID-19 Controls. Clinical Infectious Diseases , 73, E2838-E2839. https://doi.org/10.1093/cid/ciaa1594
Lai, C.C. and Yu, W.L. (2021) COVID-19 Associated with Pulmonary Aspergillosis: A Literature Review. Journal of Microbiology , Immunology and Infection , 54, 46-53. https://doi.org/10.1016/j.jmii.2020.09.004
Magnasco, L., Mikulska, M., Giacobbe, D.R., Taramasso, L., Vena, A., Dentone, C., Dettori, S., Tutino, S., Labate, L., et al. (2021) Spread of Carbapenem-Resistant Gram-Negatives and Candida auris during the Covid-19 Pandemic in Critically Ill Patients: One Step Back in Antimicrobial Stewardship? Microorganisms , 9, Article 95. https://doi.org/10.3390/microorganisms9010095
Rodriguez, J.Y., Le Pape, P., Lopez, O., Esquea, K., Labiosa, A.L. and Alvarez-Moreno, C. (2021) Candida auris : A Latent Threat to Critically Ill Patients with Coronavirus Disease 2019. Clinical Infectious Diseases , 73, e2836-e2837. https://doi.org/10.1093/cid/ciaa1595
Arendrup, M.C. and Patterson, T.F. (2017) Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment. The Journal of Infectious Diseases , 216, S445-S451. https://doi.org/10.1093/infdis/jix131
Pristov, K.E. and Ghannoum, M.A. (2019) Resistance of Candida to Azoles and Echinocandins Worldwide. Clinical Microbiology and Infection , 25, 792-798. https://doi.org/10.1016/j.cmi.2019.03.028
Perea, S. and Patterson, T.F. (2002) Antifungal Resistance in Pathogenic Fungi. Clinical Infectious Diseases , 35, 1073-1080. https://doi.org/10.1086/344058
Benedict, K., Whitham, H.K. and Jackson, B.R. (2022) Economic Burden of Fungal Diseases in the United States. Open Forum Infectious Diseases , 9, ofac097. https://doi.org/10.1093/ofid/ofac097
Warshaw, E.M. (2006) Evaluating Costs for Onychomycosis Treatments: A Practitioner’s Perspective. Journal of the American Podiatric Medical Association , 96, 38-52. https://doi.org/10.7547/0960038
Mei-Sheng Riley, M. (2021) Invasive Fungal Infections among Immunocompromised Patients in Critical Care Settings: Infection Prevention Risk Mitigation. Critical Care Nursing Clinics of North America , 33, 395-405. https://doi.org/10.1016/j.cnc.2021.07.002
Low, C.Y. and Rotstein, C. (2011) Emerging Fungal Infections in Immunocompromised Patients. F 1000 Medicine Reports , 3, 14. https://doi.org/10.3410/M3-14
Xia, J., Wang, Z., Li, T., Lu, F., Sheng, D. and Huang, W. (2022) Immunosuppressed Patients with Clinically Diagnosed Invasive Fungal Infections: The Fungal Species Distribution, Antifungal Sensitivity and Associated Risk Factors in a Tertiary Hospital of Anhui Province. Infection and Drug Resistance , 15, 321-333. https://doi.org/10.2147/IDR.S351260
Robertson, E., Abera, C., Wood, K., Deressa, K., Mesfin, S. and Scantlebury, C. (2023) Striving towards Access to Essential Medicines for Human and Animal Health; a Situational Analysis of Access to and Use of Antifungal Medications for Histoplasmosis in Ethiopia. PLOS ONE , 18, e0278964. https://doi.org/10.1371/journal.pone.0278964
Roemer, T. and Krysan, D.J. (2014) Antifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches. Cold Spring Harbor Perspectives in Medicine , 4, a019703. https://doi.org/10.1101/cshperspect.a019703
Ahmad, A., Molepo, J. and Patel, M. (2016) Challenges in the Development of Antifungal Agents against Candida: Scope of Phytochemical Research. Current Pha r maceutical Design , 22, 4135-4150. https://doi.org/10.2174/1381612822666160607072748
Rodrigues, M.L. and Nosanchuk, J.D. (2023) Recognition of Fungal Priority Pathogens: What Next? PLOS Neglected Tropical Diseases , 17, e0011136. https://doi.org/10.1371/journal.pntd.0011136
Hudson, M.M.T. (2001) Antifungal Resistance and Over-the-Counter Availability in the UK: A Current Perspective. Journal of Antimicrobial Chemotherapy , 48, 345-350. https://doi.org/10.1093/jac/48.3.345
Kneale, M., Bartholomew, J.S., Davies, E. and Denning, D.W. (2016) Global Access to Antifungal Therapy and Its Variable Cost. Journal of Antimicrobial Chemoth e rapy , 71, 3599-3606. https://doi.org/10.1093/jac/dkw325
Khairy, W.A., Nasser, H.A., Sarhan, M.D., El Shamy, A.A. and Galal, Y.S. (2021) Prevalence and Predictors of Self-Medication with Antifungal Drugs and Herbal Products among University Students: A Cross-Sectional Study from Egypt. Risk Management and Healthcare Policy , 14, 2191-2200. https://doi.org/10.2147/RMHP.S308400
Revie, N.M., Iyer, K.R., Robbins, N. and Cowen, L.E. (2018) Antifungal Drug Resistance: Evolution, Mechanisms and Impact. Current Opinion in Microbiology , 45, 70-76. https://doi.org/10.1016/j.mib.2018.02.005
Zhao, Y., Ye, L., Zhao, F., Zhang, L., Lu, Z., Chu, T., Wang, S., Liu, Z., Sun, Y., Chen, M., et al. (2023) Cryptococcus neoformans, a Global Threat to Human Health. Infectious Diseases of Poverty , 12, Article No. 20. https://doi.org/10.1186/s40249-023-01073-4
Xu, J. (2022) Assessing Global Fungal Threats to Humans. mLife , 1, 223-240. https://doi.org/10.1002/mlf2.12036
Rhodes, J. (2019) Rapid Worldwide Emergence of Pathogenic Fungi. Cell Host & Microbe , 26, 12-14. https://doi.org/10.1016/j.chom.2019.06.009
Lima, R., Ribeiro, F.C., Colombo, A.L. and de Almeida, J.N. (2022) The Emerging Threat Antifungal-Resistant Candida tropicalis in Humans, Animals, and Environment. Frontiers in Fungal Biology , 3, Article 957021. https://doi.org/10.3389/ffunb.2022.957021
Drgona, L., Khachatryan, A., Stephens, J., Charbonneau, C., Kantecki, M., Haider, S. and Barnes, R. (2014) Clinical and Economic Burden of Invasive Fungal Diseases in Europe: Focus on Pre-Emptive and Empirical Treatment of Aspergillus and Candida Species. European Journal of Clinical Microbiology & Infectious Diseases , 33, 7-21. https://doi.org/10.1007/s10096-013-1944-3
Slobbe, L., Polinder, S., Doorduijn, J.K., Lugtenburg, P.J., El Barzouhi, A., Steyerberg, E.W. and Rijnders, B.J.A. (2008) Outcome and Medical Costs of Patients with Invasive Aspergillosis and Acute Myelogenous Leukemia-Myelodysplastic Syndrome Treated with Intensive Chemotherapy: An Observational Study. Clinical I n fectious Diseases , 47, 1507-1512. https://doi.org/10.1086/591531
Berger, S., Chazli, Y. El Babu, A.F. and Coste, A.T. (2017) Azole Resistance in A s pergillus fumigatus : A Consequence of Antifungal Use in Agriculture? Frontiers in Microbiology , 8, Article 1024. https://doi.org/10.3389/fmicb.2017.01024
Stevenson, E.M., Gaze, W.H., Gow, N.A.R., Hart, A., Schmidt, W., Usher, J., Warris, A., Wilkinson, H. and Murray, A.K. (2022) Antifungal Exposure and Resistance Development: Defining Minimal Selective Antifungal Concentrations and Testing Methodologies. Frontiers in Fungal Biology , 3, Article 918717. https://doi.org/10.3389/ffunb.2022.918717
Burks, C., Darby, A., Londoño, L.G., Momany, M. and Brewer, M.T. (2021) Azole-Resistant Aspergillus fumigatus in the Environment: Identifying Key Reservoirs and Hotspots of Antifungal Resistance. PLOS Pathogens , 17, e1009711. https://doi.org/10.1371/journal.ppat.1009711
Picot, S., Beugnet, F., Leboucher, G. and Bienvenu, A.L. (2022) Drug Resistant Parasites and Fungi from a One-Health Perspective: A Global Concern That Needs Transdisciplinary Stewardship Programs. One Health , 14, Article 100368. https://doi.org/10.1016/j.onehlt.2021.100368
Verweij, P.E., Arendrup, M.C., Alastruey-Izquierdo, A., Gold, J.A.W., Lockhart, S.R., Chiller, T. and White, P.L. (2022) Dual Use of Antifungals in Medicine and Agriculture: How Do We Help Prevent Resistance Developing in Human Pathogens? Drug Resistance Updates , 65, Article 100885. https://doi.org/10.1016/j.drup.2022.100885
Verweij, P.E., Lucas, J.A., Arendrup, M.C., Bowyer, P., Brinkmann, A.J.F., Denning, D.W., Dyer, P.S., Fisher, M.C., Geenen, P.L., Gisi, U., et al. (2020) The One Health Problem of Azole Resistance in Aspergillus fumigatus : Current Insights and Future Research Agenda. Fungal Biology Reviews , 34, 202-214. https://doi.org/10.1016/j.fbr.2020.10.003
Sahu, S., Panda, A., Dash, S., Ramani, Y.R. and Behera, J. (2023) Changing Pattern of Antifungal Drug Resistance in a Tertiary Health-Care Facility—A Cross-Sectional Study. Current Medical Issues , 21, 208-213. https://doi.org/10.4103/cmi.cmi_63_23
Prajna, N.V., Lalitha, P., Krishnan, T., Rajaraman, R., Radnakrishnan, N., Srinivasan, M., Devi, L., Das, M., Liu, Z., Zegans, M.E., et al. (2022) Patterns of Antifungal Resistance in Adult Patients with Fungal Keratitis in South India: A Post Hoc Analysis of 3 Randomized Clinical Trials. JAMA Ophthalmology , 140, 179-184. https://doi.org/10.1001/jamaophthalmol.2021.5765
Sarma, S., Kumar, N., Sharma, S., Govil, D., Ali, T., Mehta, Y. and Rattan, A. (2013) Candidemia Caused by Amphotericin B and Fluconazole Resistant Candida auris . Indian Journal of Medical Microbiology , 31, 90-91. https://doi.org/10.4103/0255-0857.108746
Achilonu, C.C., Davies, A., Kanu, O.O., Noel, C.B. and Oladele, R. (2023) Recent Advances and Future Perspectives in Mitigating Invasive Antifungal-Resistant Pathogen Aspergillus fumigatus in Africa. Current Treatment Options in Infectious Diseases , 16, 14-33. https://doi.org/10.1007/s40506-023-00269-4
Allaw, F., Zahreddine, N.K., Ibrahim, A., Tannous, J., Taleb, H., Bizri, A.R., Dbaibo, G. and Kanj, S.S. (2021) First Candida auris Outbreak during a Covid-19 Pandemic in a Tertiary-Care Center in Lebanon. Pathogens , 10, Article 157. https://doi.org/10.3390/pathogens10020157
Jacobs, S.E., Jacobs, J.L., Dennis, E.K., Taimur, S., Rana, M., Patel, D., Gitman, M., Patel, G., Schaefer, S., Iyer, K., et al. (2022) Candida auris Pan-Drug-Resistant to Four Classes of Antifungal Agents. Antimicrobial Agents and Chemotherapy , 66, e0005322. https://doi.org/10.1128/aac.00053-22
Purkait, B., Kumar, A., Nandi, N., Sardar, A.H., Das, S., Kumar, S., Pandey, K., Ravidas, V., Kumar, M., De, T., et al. (2012) Mechanism of Amphotericin B Resistance in Clinical Isolates of Leishmania donovani . Antimicrobial Agents and Ch e motherapy , 56, 1031-1041. https://doi.org/10.1128/AAC.00030-11
Mano, C., Kongkaew, A., Tippawangkosol, P., Somboon, P., Roytrakul, S., Pescher, P., Späth, G.F., Uthaipibull, C., Tantiworawit, A., Siriyasatien, P., et al. (2023) Amphotericin B Resistance Correlates with Increased Fitness in Vitro and in Vivo in Leishmania (Mundinia) Martiniquensis. Frontiers in Microbiology , 14, Article 1156061. https://doi.org/10.3389/fmicb.2023.1156061
Silva, L.N., Oliveira, S.S.C., Magalhães, L.B., Andrade Neto, V. V., Torres-Santos, E.C., Carvalho, M.D.C., Pereira, M.D., Branquinha, M.H. and Santos, A.L.S. (2020) Unmasking the Amphotericin B Resistance Mechanisms in Candida haemulonii Species Complex. ACS Infectious Diseases , 6, 1273-1282. https://doi.org/10.1021/acsinfecdis.0c00117
Messer, S.A., Diekema, D.J., Boyken, L., Tendolkar, S., Hollis, R.J. and Pfaller, M.A. (2006) Activities of Micafungin against 315 Invasive Clinical Isolates of Fluconazole-Resistant Candida Spp. Journal of Clinical Microbiology , 44, 324-326. https://doi.org/10.1128/JCM.44.2.324-326.2006
Alexander, B.D., Johnson, M.D., Pfeiffer, C.D., Jiménez-Ortigosa, C., Catania, J., Booker, R., Castanheira, M., Messer, S.A., Perlin, D.S. and Pfaller, M.A. (2013) Increasing Echinocandin Resistance in Candida glabrata : Clinical Failure Correlates with Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations. Clinical Infectious Diseases , 56, 1724-1732. https://doi.org/10.1093/cid/cit136
Healey, K.R. and Perlin, D.S. (2018) Fungal Resistance to Echinocandins and the MDR Phenomenon in Candida glabrata . Journal of Fungi , 4, Article 105. https://doi.org/10.3390/jof4030105
Perlin, D.S. (2015) Mechanisms of Echinocandin Antifungal Drug Resistance. A n nals of the New York Academy of Sciences , 1354, 1-11. https://doi.org/10.1111/nyas.12831
Farmakiotis, D., Tarrand, J.J. and Kontoyiannis, D.P. (2014) Drug-Resistant Cand i da glabrata Infection in Cancer Patients. Emerging Infectious Diseases , 20, 1833-1840. https://doi.org/10.3201/eid2011.140685
Thompson, G.R., Wiederhold, N.P., Vallor, A.C., Villareal, N.C., Lewis, J.S. and Patterson, T.F. (2008) Development of Caspofungin Resistance Following Prolonged Therapy for Invasive Candidiasis Secondary to Candida glabrata Infection. Antimicrobial Agents and Chemotherapy , 52, 3783-3785. https://doi.org/10.1128/AAC.00473-08
Satoh, K., Makimura, K., Hasumi, Y., Nishiyama, Y., Uchida, K. and Yamaguchi, H. (2009) Candida auris Sp. Nov., a Novel Ascomycetous Yeast Isolated from the External Ear Canal of an Inpatient in a Japanese Hospital. Microbiology and Imm u nology , 53, 41-44. https://doi.org/10.1111/j.1348-0421.2008.00083.x
Chowdhary, A., Voss, A. and Meis, J.F. (2016) Multidrug-Resistant Candida auris : ‘New Kid on the Block’ in Hospital-Associated Infections? Journal of Hospital I n fection , 94, 209-212. https://doi.org/10.1016/j.jhin.2016.08.004
Chowdhary, A., Tarai, B., Singh, A. and Sharma, A. (2020) Multidrug-Resistant Candida auris Infections in Critically Ill Coronavirus Disease Patients, India, April-July 2020. Emerging Infectious Diseases , 26, 2694-2696. https://doi.org/10.3201/eid2611.203504
Pfaller, M.A., Messer, S.A., Moet, G.J., Jones, R.N. and Castanheira, M. (2011) Candida Bloodstream Infections: Comparison of Species Distribution and Resistance to Echinocandin and Azole Antifungal Agents in Intensive Care Unit (ICU) and Non-ICU Settings in the SENTRY Antimicrobial Surveillance Program (2008-2009). International Journal of Antimicrobial Agents , 38, 65-69. https://doi.org/10.1016/j.ijantimicag.2011.02.016
Beyda, N.D., John, J., Kilic, A., Alam, M.J., Lasco, T.M. and Garey, K.W. (2014) FKS Mutant Candida glabrata : Risk Factors and Outcomes in Patients with Candidemia. Clinical Infectious Diseases , 59, 819-825. https://doi.org/10.1093/cid/ciu407
Pfaller, M.A., Castanheira, M., Messer, S.A. and Jones, R.N. (2015) In Vitro Antifungal Susceptibilities of Isolates of Candida Spp. and Aspergillus Spp. from China to Nine Systemically Active Antifungal Agents: Data from the SENTRY Antifungal Surveillance Program, 2010 through 2012. Mycoses , 58, 209-214. https://doi.org/10.1111/myc.12299
Xu, Z., Zhang, L., Han, R., Ding, C., Shou, H., Duan, X. and Zhang, S. (2023) A Candidemia Case Caused by a Novel Drug-Resistant Candida auris with the Y132f Mutation in Ergii in Mainland China. Infection and Drug Resistance , 16, 3065-3072. https://doi.org/10.2147/IDR.S409708
Khan, Z.U., Al-Sweih, N.A., Ahmad, S., Al-Kazemi, N., Khan, S., Joseph, L. and Chandy, R. (2007) Outbreak of Fungemia among Neonates Caused by Candida haemulonii Resistant to Amphotericin B, Itraconazole, and Fluconazole. Journal of Clinical Microbiology , 45, 2025-2027. https://doi.org/10.1128/JCM.00222-07
Kim, M.N., Shin, J.H., Sung, H., Lee, K., Kim, E.C., Ryoo, N., Lee, J.S., Jung, S.L., Park, K.H., Kee, S.J., et al. (2009) Candida haemulonii and Closely Related Species at 5 University Hospitals in Korea: Identification, Antifungal Susceptibility, and Clinical Features. Clinical Infectious Diseases , 48, e57-61. https://doi.org/10.1086/597108
Galia, L., Pezzani, M.D., Compri, M., Callegari, A., Rajendran, N.B., Carrara, E. and Tacconelli, E. (2022) Surveillance of Antifungal Resistance in Candidemia Fails to Inform Antifungal Stewardship in European Countries. Journal of Fungi , 8, Article 249. https://doi.org/10.3390/jof8030249
Woods, M., McAlister, J.A. and Geddes-McAlister, J. (2023) A One Health Approach to Overcoming Fungal Disease and Antifungal Resistance. WIREs Mecha n isms of Disease , 15, e1610. https://doi.org/10.1002/wsbm.1610
Urbancic, K.F., Thursky, K., Kong, D.C.M., Johnson, P.D.R. and Slavin, M.A. (2018) Antifungal Stewardship: Developments in the Field. Current Opinion in Infectious Diseases , 31, 490-498. https://doi.org/10.1097/QCO.0000000000000497
Nivoix, Y., Launoy, A., Lutun, P., Moulin, J.C., Phai Pang, K.A., Fornecker, L.M., Wolf, M., Levěque, D., Letscher-Bru, V., Beretz, L., et al. (2012) Adherence to Recommendations for the Use of Antifungal Agents in a Tertiary Care Hospital. Jou r nal of Antimicrobial Chemotherapy , 67, 2506-2513. https://doi.org/10.1093/jac/dks256
Albahar, F., Alhamad, H., Abu Assab, M., Abu-Farha, R., Alawi, L. and Khaleel, S. (2024) The Impact of Antifungal Stewardship on Clinical and Performance Measures: A Global Systematic Review. Tropical Medicine and Infectious Disease , 9, Article 8. https://doi.org/10.3390/tropicalmed9010008
Samura, M., Hirose, N., Kurata, T., Ishii, J., Nagumo, F., Takada, K., Koshioka, S., Uchida, M., Yamamoto, S., Inoue, J., et al. (2020) Support for Fungal Infection Treatment Mediated by Pharmacist-Led Antifungal Stewardship Activities. Journal of Infection and Chemotherapy , 26, 272-279. https://doi.org/10.1016/j.jiac.2019.09.016
Cook, P.P. and Gooch, M. (2015) Long-Term Effects of an Antimicrobial Stewardship Programme at a Tertiary-Care Teaching Hospital. International Journal of A n timicrobial Agents , 45, 262-267. https://doi.org/10.1016/j.ijantimicag.2014.11.006
Alegria, W. and Patel, P.K. (2021) The Current State of Antifungal Stewardship in Immunocompromised Populations. Journal of Fungi , 7, Article 352. https://doi.org/10.3390/jof7050352
Valerio, M., Muñoz, P., Rodríguez-González, C., Sanjurjo, M., Guinea, J. and Bouza, E. (2015) Training Should Be the First Step toward an Antifungal Stewardship Program. Enfermedades Infecciosas y Microbiología Clínica , 33, 221-227. https://doi.org/10.1016/j.eimc.2014.04.016
Mondain, V., Lieutier, F., Hasseine, L., Gari-Toussaint, M., Poiree, M., Lions, C. and Pulcini, C. (2013) A 6-Year Antifungal Stewardship Programme in a Teaching Hospital. Infection , 41, 621-628. https://doi.org/10.1007/s15010-013-0431-1
Talento, A.F., Qualie, M., Cottom, L., Backx, M. and White, P.L. (2021) Lessons from an Educational Invasive Fungal Disease Conference on Hospital Antifungal Stewardship Practices across the UK and Ireland. Journal of Fungi , 7, Article 801. https://doi.org/10.3390/jof7100801
Mudenda, S., Daka, V. and Matafwali, S.K. (2023) World Health Organization AWaRe Framework for Antibiotic Stewardship: Where Are We Now and Where Do We Need to Go? An Expert Viewpoint. Antimicrobial Stewardship & Healthcare Epidemiology , 3, e84. https://doi.org/10.1017/ash.2023.164
World Health Organization (2023) AWaRe Classification of Antibiotics for Evaluation and Monitoring of Use. https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2023.04
Graham, K., Sinyangwe, C., Nicholas, S., King, R., Mukupa, S., Källander, K., Counihan, H., Montague, M., Tibenderana, J. and Hamade, P. (2016) Rational Use of Antibiotics by Community Health Workers and Caregivers for Children with Suspected Pneumonia in Zambia: A Cross-Sectional Mixed Methods Study. BMC Pu b lic Health , 16, Article No. 897. https://doi.org/10.1186/s12889-016-3541-8
Hagen, T.L., Hertz, M.A., Uhrin, G.B., Dalager-Pedersen, M., Schønheyder, H.C. and Nielsen, H. (2017) Adherence to Local Antimicrobial Guidelines for Initial Treatment of Community-Acquired Infections. Danish Medical Journal , 64, A5381.
Mekonnen Eticha, E. and Gemechu, W.D. (2021) Adherence to Guidelines for Assessment and Empiric Antibiotics Recommendations for Community-Acquired Pneumonia at Ambo University Referral Hospital: Prospective Observational Study. Patient Preference and Adherence , 15, 467-473. https://doi.org/10.2147/PPA.S295118
Tell, D., Engström, S. and Mölstad, S. (2015) Adherence to Guidelines on Antibiotic Treatment for Respiratory Tract Infections in Various Categories of Physicians: A Retrospective Cross-Sectional Study of Data from Electronic Patient Records. BMJ Open , 5, e008096. https://doi.org/10.1136/bmjopen-2015-008096
Boltena, M.T., Woldie, M., Siraneh, Y., Steck, V., El-Khatib, Z. and Morankar, S. (2023) Adherence to Evidence-Based Implementation of Antimicrobial Treatment Guidelines among Prescribers in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. Journal of Pharmaceutical Policy and Practice , 16, Article 137. https://doi.org/10.1186/s40545-023-00634-0
Wiedenmayer, K., Ombaka, E., Kabudi, B., Canavan, R., Rajkumar, S., Chilunda, F., Sungi, S. and Stoermer, M. (2021) Adherence to Standard Treatment Guidelines among Prescribers in Primary Healthcare Facilities in the Dodoma Region of Tanzania. BMC Health Services Research , 21, Article No. 272. https://doi.org/10.1186/s12913-021-06257-y
Metz, J., Oehler, P., Burggraf, M., Burdach, S., Behrends, U. and Rieber, N. (2019) Improvement of Guideline Adherence after the Implementation of an Antibiotic Stewardship Program in a Secondary Care Pediatric Hospital. Frontiers in Pedi a trics , 7, Article 478. https://doi.org/10.3389/fped.2019.00478
Barlam, T.F., Cosgrove, S.E., Abbo, L.M., Macdougall, C., Schuetz, A.N., Septimus, E.J., Srinivasan, A., Dellit, T.H., Falck-Ytter, Y.T., Fishman, N.O., et al. (2016) Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clinical Infectious Diseases , 62, e51-e77. https://doi.org/10.1093/cid/ciw118
Rabaan, A.A., Sulaiman, T., Al-Ahmed, S.H., Buhaliqah, Z.A., Buhaliqah, A.A., AlYuosof, B., Alfaresi, M., Al Fares, M.A., Alwarthan, S., Alkathlan, M.S., et al. (2023) Potential Strategies to Control the Risk of Antifungal Resistance in Humans: A Comprehensive Review. Antibiotics , 12, Article 608. https://doi.org/10.3390/antibiotics12030608
McCarty, T.P. and Pappas, P.G. (2021) Antifungal Pipeline. Frontiers in Cellular and Infection Microbiology , 11, Article 732223. https://doi.org/10.3389/fcimb.2021.732223
Castelli, M.V., Butassi, E., Monteiro, M.C., Svetaz, L.A., Vicente, F. and Zacchino, S.A. (2014) Novel Antifungal Agents: A Patent Review (2011-Present). Expert Op i nion on Therapeutic Patents , 24, 323-338. https://doi.org/10.1517/13543776.2014.876993
Fuentefria, A.M., Pippi, B., Dalla Lana, D.F., Donato, K.K. and de Andrade, S.F. (2018) Antifungals Discovery: An Insight into New Strategies to Combat Antifungal Resistance. Letters in Applied Microbiology , 66, 2-13. https://doi.org/10.1111/lam.12820
Durdu, M. and Ilkit, M. (2023) Strategies to Improve the Diagnosis and Clinical Treatment of Dermatophyte Infections. Expert Review of Anti-Infective Therapy , 21, 29-40. https://doi.org/10.1080/14787210.2023.2144232
Smith, D.J., Gold, J.A.W., Benedict, K., Wu, K., Lyman, M., Jordan, A., Medina, N., Lockhart, S.R., Sexton, D.J., Chow, N.A., et al. (2023) Public Health Research Priorities for Fungal Diseases: A Multidisciplinary Approach to Save Lives. Journal of Fungi , 9, Article 820. https://doi.org/10.3390/jof9080820
Sanguinetti, M., Posteraro, B., Beigelman-Aubry, C., Lamoth, F., Dunet, V., Slavin, M. and Richardson, M.D. (2019) Diagnosis and Treatment of Invasive Fungal Infections: Looking Ahead. Journal of Antimicrobial Chemotherapy , 74, II27-II37. https://doi.org/10.1093/jac/dkz041
Scorzoni, L., de Paula e Silva, A.C.A., Marcos, C.M., Assato, P.A., de Melo, W.C.M.A., de Oliveira, H.C., Costa-Orlandi, C.B., Mendes-Giannini, M.J.S. and Fusco-Almeida, A.M. (2017) Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis. Frontiers in Microbiology , 8, Article 36. https://doi.org/10.3389/fmicb.2017.00036
Skosana, P.P., Mudenda, S., Demana, P.H. and Witika, B.A. (2023) Exploring Nanotechnology as a Strategy to Circumvent Antimicrobial Resistance in Bone and Joint Infections. ACS Omega , 8, 15865-15882. https://doi.org/10.1021/acsomega.3c01225
Mali, R. and Patil, J. (2023) Nanoparticles: A Novel Antifungal Drug Delivery System. Antibiotics , 14, Article 61. https://doi.org/10.3390/IOCN2023-14513
Al-Jedai, A.H., Almogbel, Y., Eljaaly, K., Alqahtani, N.M., Almudaiheem, H.Y., Awad, N., Alissa, D.A., Assiri, A. and Alaama, T. (2022) Restriction on Antimicrobial Dispensing without Prescription on a National Level: Impact on the Overall Antimicrobial Utilization in the Community Pharmacies in Saudi Arabia. PLOS ONE , 17, e0271188. https://doi.org/10.1371/journal.pone.0271188
Rawson, T.M., Antcliffe, D.B., Wilson, R.C., Abdolrasouli, A. and Moore, L.S.P. (2023) Management of Bacterial and Fungal Infections in the ICU: Diagnosis, Treatment, and Prevention Recommendations. Infection and Drug Resistance , 16, 2709-2726. https://doi.org/10.2147/IDR.S390946
Storr, J., Twyman, A., Zingg, W., Damani, N., Kilpatrick, C., Reilly, J., Price, L., Egger, M., Grayson, M.L., Kelley, E., et al. (2017) Core Components for Effective Infection Prevention and Control Programmes: New WHO Evidence-Based Recommendations. Antimicrobial Resistance & Infection Control , 6, Article No. 6. https://doi.org/10.1186/s13756-016-0149-9
Moore, D.P., Chetty, T., Pillay, A., Karsas, M., Cloete, J., Balakrishna, Y., Reddy, T., Archary, M., van Kwawegen, A., Thomas, R., et al. (2024) Antibiotic and Antifungal Use in Paediatric Departments at Three Academic Hospitals in South Africa. IJID Regions , 10, 151-158. https://doi.org/10.1016/j.ijregi.2023.12.004
Nagel, J.L., Kaye, K.S., LaPlante, K.L. and Pogue, J.M. (2016) Antimicrobial Stewardship for the Infection Control Practitioner. Infectious Disease Clinics of North America , 30, 771-784. https://doi.org/10.1016/j.idc.2016.04.012
Zhou, S., Nagel, J.L., Kaye, K.S., LaPlante, K.L., Albin, O.R. and Pogue, J.M. (2021) Antimicrobial Stewardship and the Infection Control Practitioner: A Natural Alliance. Infectious Disease Clinics of North America , 35, 771-787. https://doi.org/10.1016/j.idc.2021.04.011
Senbato, F.R., Wolde, D., Belina, M., Kotiso, K.S., Medhin, G., Amogne, W. and Eguale, T. (2024) Compliance with Infection Prevention and Control Standard Precautions and Factors Associated with Noncompliance among Healthcare Workers Working in Public Hospitals in Addis Ababa, Ethiopia. Antimicrobial Resistance & Infection Control , 13, Article No. 32. https://doi.org/10.1186/s13756-024-01381-w
Abalkhail, A. and Alslamah, T. (2022) Institutional Factors Associated with Infection Prevention and Control Practices Globally during the Infectious Pandemics in Resource-Limited Settings. Vaccines , 10, Article 1811. https://doi.org/10.3390/vaccines10111811
Das, A., Garg, R., Kumar, E.S., Singh, D., Ojha, B., Kharchandy, H.L., Pathak, B.K., Srikrishnan, P., Singh, R., Joshua, I., et al. (2022) Implementation of Infection Prevention and Control Practices in an Upcoming COVID-19 Hospital in India: An Opportunity Not Missed. PLOS ONE , 17, e0268071. https://doi.org/10.1371/journal.pone.0268071
Mustafa, Z.U., Majeed, H.K., Latif, S., Salman, M., Hayat, K., Mallhi, T.H., Khan, Y.H., Khan, A.H., Abubakar, U., Sultana, K., et al. (2023) Adherence to Infection Prevention and Control Measures among Health-Care Workers Serving in COVID-19 Treatment Centers in Punjab, Pakistan. Disaster Medicine and Public Health Preparedness , 17, e298. https://doi.org/10.1017/dmp.2022.252
Ling, M.L., Ching, P., Cheng, J., Lang, L., Liberali, S., Poon, P., Shin, Y. and Sim, C. (2023) APSIC Dental Infection Prevention and Control (IPC) Guidelines. Antim i crobial Resistance & Infection Control , 12, Article No. 53. https://doi.org/10.1186/s13756-023-01252-w
Gahamanyi, N., Umuhoza, T., Saeed, S.I., Mayigane, L.N. and Hakizimana, J.N. (2023) A Review of the Important Weapons against Antimicrobial Resistance in Sub-Saharan Africa. Applied Biosciences , 2, 136-156. https://doi.org/10.3390/applbiosci2020011
Ben-Ami, R., Halaburda, K., Klyasova, G., Metan, G., Torosian, T. and Akova, M. (2013) A Multidisciplinary Team Approach to the Management of Patients with: Suspected or Diagnosed Invasive Fungal Disease. Journal of Antimicrobial Chem o therapy , 68, iii25-iii33. https://doi.org/10.1093/jac/dkt390
Janssen, N.A.F., Brüggemann, R.J.M., Reijers, M.H., Henriet, S.S.V., Ten Oever, J., de Mast, Q., Berk, Y., de Kort, E.A., Kullberg, B.J., Netea, M.G., et al. (2020) A Multidisciplinary Approach to Fungal Infections: One-Year Experiences of a Center of Expertise in Mycology. J ournal of Fungi , 6, Article 274. https://doi.org/10.3390/jof6040274
Ashiru-Oredope, D., Langford, B.J., Bonaconsa, C., Nampoothiri, V., Charani, E. and Goff, D.A. (2023) Global Collaborations in Antimicrobial Stewardship: All Hands on Deck. Antimicrobial Stewardship & Healthcare Epidemiology , 3, e66. https://doi.org/10.1017/ash.2023.122
Ashiru-Oredope, D., Nabiryo, M., Zengeni, L., Kamere, N., Makotose, A., Olaoye, O., Townsend, W., Waddingham, B., Matuluko, A., Nambatya, W., et al. (2023) Tackling Antimicrobial Resistance: Developing and Implementing Antimicrobial Stewardship Interventions in Four African Commonwealth Countries through a Health Partnership Model. Journal of Public Health in Africa , 14, 2335.
Lakoh, S., Bawoh, M., Lewis, H., Jalloh, I., Thomas, C., Barlatt, S., Jalloh, A., Deen, G.F., Russell, J.B.W., Kabba, M.S., et al. (2023) Establishing an Antimicrobial Stewardship Program in Sierra Leone: A Report of the Experience of a Low-Income Country in West Africa. Antibiotics , 12, Article 424. https://doi.org/10.3390/antibiotics12030424
Veepanattu, P., Singh, S., Mendelson, M., Nampoothiri, V., Edathadatil, F., Surendran, S., Bonaconsa, C., Mbamalu, O., Ahuja, S., Birgand, G., et al. (2020) Building Resilient and Responsive Research Collaborations to Tackle Antimicrobial Resistance—Lessons Learnt from India, South Africa, and UK. International Journal of Infectious Diseases , 100, 278-282. https://doi.org/10.1016/j.ijid.2020.08.057
Moyo, P., Moyo, E., Mangoya, D., Mhango, M., Mashe, T., Imran, M. and Dzinamarira, T. (2023) Prevention of Antimicrobial Resistance in Sub-Saharan Africa: What Has Worked? What Still Needs to Be Done? Journal of Infection and Public Health, 16, 632-639. https://doi.org/10.1016/j.jiph.2023.02.020
Musa, K., Okoliegbe, I., Abdalaziz, T., Aboushady, A.T., Stelling, J. and Gould, I.M. (2023) Laboratory Surveillance, Quality Management, and Its Role in Addressing Antimicrobial Resistance in Africa: A Narrative Review. Antibiotics , 12, Article 1313. https://doi.org/10.3390/antibiotics12081313
Iwu, C.D. and Patrick, S.M. (2021) An Insight into the Implementation of the Global Action Plan on Antimicrobial Resistance in the WHO African Region: A Roadmap for Action. International Journal of Antimicrobial Agents , 58, Article 106411. https://doi.org/10.1016/j.ijantimicag.2021.106411
Mader, R., Muñoz Madero, C., Aasmäe, B., Bourély, C., Broens, E.M., Busani, L., Callens, B., Collineau, L., Crespo-Robledo, P., Damborg, P., et al. (2022) Review and Analysis of National Monitoring Systems for Antimicrobial Resistance in Animal Bacterial Pathogens in Europe: A Basis for the Development of the European Antimicrobial Resistance Surveillance Network in Veterinary Medicine (EARS-Vet). Frontiers in Microbiology , 13, Article 807. https://doi.org/10.3389/fmicb.2022.838490
Arieti, F., Göpel, S., Sibani, M., Carrara, E., Pezzani, M.D., Murri, R., Mutters, N.T., Lòpez-Cerero, L., Voss, A., Cauda, R., et al. (2020) White Paper: Bridging the Gap between Surveillance Data and Antimicrobial Stewardship in the Outpatient Sector—Practical Guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net Networks. Journal of Antimicrobial Chemotherapy , 75, II42-II51. https://doi.org/10.1093/jac/dkaa428
He, S., Shrestha, P., Henry, A.D. and Legido-Quigley, H. (2023) Leveraging Collaborative Research Networks against Antimicrobial Resistance in Asia. Frontiers in Public Health , 11, Article 1191036. https://doi.org/10.3389/fpubh.2023.1191036
World Health Organization (2024) Regulation and Prequalification. https://www.who.int/teams/regulation-prequalification/regulation-and-safety/regulatory-convergence-networks/harmonization?page=10
Kållberg, C., Mathiesen, L., Gopinathan, U. and Salvesen Blix, H. (2023) The Role of Drug Regulatory Authorities and Health Technology Assessment Agencies in Shaping Incentives for Antibiotic R&D: A Qualitative Study. Journal of Pharm a ceutical Policy and Practice , 16, Article 53. https://doi.org/10.1186/s40545-023-00556-x
Kirchhelle, C., Atkinson, P., Broom, A., Chuengsatiansup, K., Ferreira, J.P., Fortané, N., Frost, I., Gradmann, C., Hinchliffe, S., Hoffman, S.J., et al. (2020) Setting the Standard: Multidisciplinary Hallmarks for Structural, Equitable and Tracked Antibiotic Policy. BMJ Global Health , 5, e003091. https://doi.org/10.1136/bmjgh-2020-003091
Muteeb, G., Rehman, M.T., Shahwan, M. and Aatif, M. (2023) Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review. Pharmaceuticals , 16, Article 1615. https://doi.org/10.3390/ph16111615